HR Execs on the Move


 
Lodding Corp is a Leicester, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Active Ice Inc

Active Ice Inc is a Norman, OK-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Danaher

Danaher is a diversified technology leader that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers.

Oola Life

Founded in 2012 by international bestselling authors, work-life balance experts, and holistic healthcare providers, Dr. Dave Braun and Dr. Troy Amdahl, Oola provides a simple and easy-to-follow lifestyle framework designed to lead you, step by step, to a life of less stress, more personal growth, and a clearer path toward living your unique purpose. The concept originally ideated in 1997 as Dr. Braun and Dr. Amdahl worked to better themselves in the seven key areas of life -- Fitness, Finance, Family, Field (career), Faith, Friends, and Fun. Since then, the Oola lifestyle has become a global phenomenon, with over a million followers in 40 countries actively creating their best lives. In 2021, Oola announced an affordable personal development eLearning platform to add to their offerings. Expected to launch in Summer 2021, the new platform will accelerate Oola`s goal of impacting one billion lives in seven years.

Huggins Hospital

Huggins Hospital is one of the leading companies in Healthcare, Pharmaceuticals, & Biotech industry. Huggins Hospital is based in Wolfeboro, NH. You can find more information on Huggins Hospital at www.hugginshospital.org

SetPoint Medical

SetPoint Medical is developing novel neuromodulation therapies to treat those who suffer from inflammatory diseases such as Crohn`s Disease and rheumatoid arthritis. The company is developing a proprietary and innovative neuromodulation therapy delivery platform consisting of a micro-regulator programmed via a unique prescription pad based interface. This novel therapy will provide patients and healthcare providers with a safe and efficacious alternative to drugs, while costing payors less than 50% of what today`s leading biologic therapies cost.